Cancer Research and Treatment10.4143/crt.2015.1722016482508-517<sup>18</sup>F-FDG/PET May Help to Identify a Subgroup of Patients with T1-T2 Breast Cancer and 1-3 Positive Lymph Nodes Who Are at a High Risk of Recurrence after MastectomyJee Suk Chang, Jeongshim Lee, Hyun Jung Kim, Kyung Hwan Kim, Mijin Yun, Seung Il Kim, Ki Chang Keum, Chang-Ok Suh, Yong Bae Kim,,
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2015.07.6172015933E2918F-FDG/PET May Help to Identify a Subgroup of Patients With T1–2 Breast Cancer and 1–3 Positive Lymph Nodes Who Are at a High Risk of Recurrence After MastectomyJ.S. Chang, J. Lee, K.H. Kim, K.C. Keum, C.O. Suh, Y.B. Kim,
Cancer10.1002/cncr.306582017123142626-2633Are there patients with T1 to T2, lymph node-negative breast cancer who are “high-risk” for locoregional disease recurrence?Anita Mamtani, Sujata Patil, Michelle M. Stempel, Monica Morrow,
Bioscience Reports10.1042/bsr201818532019399Can a subgroup at high risk for LRR be identified from T1-2 breast cancer with negative lymph nodes after mastectomy? A meta-analysisGongling Peng, Zhuohui Zhou, Ming Jiang, Fan Yang,
Breast Cancer10.1007/s12282-012-0369-72012212177-182Are there high-risk subgroups for isolated locoregional failure in patients who had T1/2 breast cancer with one to three positive lymph nodes and received mastectomy without radiotherapy?Yasushi Hamamoto, Shozo Ohsumi, Kenjiro Aogi, Syuichi Shinohara, Naomi Nakajima, Masaaki Kataoka, Shigemitsu Takashima,,
Annals of Surgical Oncology10.1245/s10434-014-3488-x20142151569-1574Impact of Molecular Subtype on Locoregional Recurrence in Mastectomy Patients with T1–T2 Breast Cancer and 1–3 Positive Lymph NodesTracy-Ann Moo, Robert McMillan, Michele Lee, Michelle Stempel, Alice Ho, Sujata Patil, Mahmoud El-Tamer,,
PLoS ONE10.1371/journal.pone.00817652013812e81765Post-Mastectomy Radiotherapy for Breast Cancer Patients with T1-T2 and 1-3 Positive Lymph Nodes: a Meta-AnalysisYaming Li, Meena S. Moran, Qiang Huo, Qifeng Yang, Bruce G. Haffty
The Oncologist10.1634/theoncologist.2012-02332013182141-147Radiotherapy Can Improve the Disease-Free Survival Rate in Triple-Negative Breast Cancer Patients with T1–T2 Disease and One to Three Positive Lymph Nodes After MastectomyXingxing Chen, Xiaoli Yu, Jiayi Chen, Zhaozhi Yang, Zhimin Shao, Zhen Zhang, Xiaomao Guo, Yan Feng,,,
Breast Diseases: A Year Book Quarterly10.1016/j.breastdis.2013.07.0432013243246-247Prognostic Significance of the Number of Positive Lymph Nodes in Women With T1-2N1 Breast Cancer Treated With Mastectomy: Should Patients With 1, 2, and 3 Positive Lymph Nodes Be Grouped Together?J. Crew, A. Dragun,
Journal of Breast Cancer10.4048/jbc.2013.16.3.3152013163315The Comparative Study of Ultrasonography, Contrast-Enhanced MRI, and18F-FDG PET/CT for Detecting Axillary Lymph Node Metastasis in T1 Breast CancerSeung Ook Hwang, Sang-Woo Lee, Hye Jung Kim, Wan Wook Kim, Ho Yong Park, Jin Hyang Jung,,